Omega Therapeutics, Inc. (OMGA) Financials

OMGA Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 183.7 million 142.3 million
2023-12-31 204.4 million 146.4 million
2023-09-30 217.8 million 141.8 million
2023-06-30 229.0 million 133.1 million

OMGA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -12.3 million 3.4 million
2023-12-31 -18.2 million 2.1 million
2023-09-30 -23.8 million 2.3 million
2023-06-30 -24.3 million 2.2 million

OMGA Net Income

No data available :(

OMGA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 60.0 million - 109.7 million
2023-12-31 73.4 million - 109.5 million
2023-09-30 89.3 million - 111.3 million
2023-06-30 113.0 million 11.6 million 98.7 million

OMGA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 55.2 million
2023-12-31 55.1 million
2023-09-30 55.1 million
2023-06-30 55.1 million

OMGA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 535000 15.4 million 7.4 million -
2023-12-31 1.1 million 15.5 million 6.2 million -1.8 million
2023-09-30 724000 16.5 million 7.9 million -
2023-06-30 1.0 million 25.0 million 6.2 million -

OMGA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 2.4 million -
2023-12-31 989000 1.8 million
2023-09-30 831000 1.9 million
2023-06-30 759000 1.8 million

OMGA

Price: $2.41

52 week price:
1.30
10.09

Earnings Per Share: -1.80 USD

P/E Ratio: -1.64

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 118.3 million

Links: